Y08060 is an effective and selective BET Inhibitor for the Treatment of Prostate Cancer. Y08060 effectively suppresses cell growth, colony formation, and expression of androgen receptor (AR), AR regulated genes, and MYC in prostate cancer cell lines. Y08060 has IC50 values of 3.23 and 4.41 µM in inhibition of cell viability in the C4 2B and LNCaP cell lines, respectively.
Molecular Weight:
471.32
Formula:
C18H19BrN2O6S
Target:
Others
T24411
* VAT and and shipping costs not included. Errors and price changes excepted
